International Forum of Allergy & Rhinology

Papers
(The H4-Index of International Forum of Allergy & Rhinology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
219
154
82
79
Incidence, risk factors, and prognostic value of nodal involvement in sinonasal cancers76
Otolaryngic sensory loss as a measure of frailty among older US adults70
Systemic steroids may enhance recovery from loss of smell and taste in hospitalized coronavirus disease 2019 (COVID‐19) patients: an observational study65
Effects of implants with steroids after endoscopic sinus surgery: A systematic review with meta‐analysis of randomized controlled trials49
Akt activator SC79 stimulates antibacterial nitric oxide generation in human nasal epithelial cells in vitro44
Reply to: “Air pollution exposure is associated with rhinitis in older US adults via specific immune mechanisms”39
Long‐term olfactory dysfunction in COVID‐19 patients: 18‐month follow‐up study38
Letter to the editor regarding “Long‐term quality‐of‐life impairment in patients with more than 1‐year COVID‐19–related olfactory dysfunction”34
Nitric oxide–generating microparticles: An in vitro evaluation of anti‐biofilm efficacy and sinonasal epithelial cell cytotoxicity34
Site‐specific detection and differential levels of immune mediators in the sinonasal mucosa34
Air pollution exposure is associated with rhinitis in older US adults via specific immune mechanisms32
The association between olfactory subdomains and frailty: A prospective case‒control study investigation31
Orbital resection by intranasal technique (ORBIT): A new classification system for reporting endoscopically resectable primary benign orbital tumors28
Letter to the editor regarding “Intralesional cidofovir injections for the treatment of multifocal exophytic sinonasal papilloma”: The utility of topical cidofovir28
Surgical complications in combined rhinoplasty and endoscopic sinus surgery28
Response to “Letter to the Editor Regarding Ambient Particulate Matter and Frequency of Outpatient Visits for Chronic Rhinosinusitis in the United States”26
Gabapentin improves parosmia after COVID‐19 infection25
Levels of nasal nitric oxide and nitric oxide synthase expression in chronic rhinosinusitis with nasal polyposis24
Optimal primer selection for sinus microbiome profiling: A comparative analysis of the V1‐V3 and V3‐4 16S target regions24
Calprotectin in chronic rhinosinusitis eosinophil extracellular traps23
0.094978809356689